Two Prestigious Awards Recognized at Asia-Pacific Biopharma Excellence Awards 2025 for Avantor®
Avantor Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technologies industries, was recently honored with two prestigious awards at the Asia-Pacific Biopharma Excellence Awards (ABEA) 2025. These accolades highlight Avantor’s ongoing commitment to advancing high-quality biopharma manufacturing solutions, overcoming logistics challenges, and optimizing supply chains to support the biopharmaceutical industry.
Avantor® Wins Two Major Awards at ABEA 2025
At the ABEA 2025 ceremony, Avantor was recognized with the following prestigious awards:
- Best Bioprocessing Supplier Award: Single Use Systems
- Best Bioprocessing Supplier Award: Chromatography
These awards acknowledge Avantor’s leadership in providing innovative and high-performance solutions that enhance flexibility, efficiency, and scalability in biopharma manufacturing. The company’s portfolio includes a wide range of cutting-edge products such as single-use systems and chromatography resins, which are crucial for developing next-generation biologic therapies.
Single-Use Solutions Driving Flexibility in Biomanufacturing
Single-use systems play a vital role in biopharma manufacturing, offering increased flexibility, faster turnaround times, and reduced costs. As the only open-architecture provider, Avantor offers comprehensive, end-to-end design, manufacturing, and logistics support on a global scale. This approach enables the company to meet the growing demands of the biopharmaceutical industry for flexible, scalable, and efficient manufacturing solutions.
Avantor’s single-use solutions allow companies to scale their operations quickly while minimizing the risk of contamination. These systems are crucial in producing biologics more efficiently, reducing waste, and streamlining the overall manufacturing process.
Chromatography: Advanced Solutions for Next-Generation Therapies
Chromatography is essential for purifying and analyzing complex biomolecules in the production of biologics. Avantor’s diverse portfolio of chromatography resins and advanced production technologies is helping the industry meet the challenges of delivering high-quality therapies at scale. The company’s advanced chromatography solutions enable rapid, efficient, and scalable purification processes for biopharmaceutical manufacturers, helping them bring life-saving therapies to market faster.
Avantor’s chromatography resins, including its PROchievA and J.T. Baker® Bakerbond® brands, provide unmatched selectivity for a wide range of next-generation therapies. These resins are particularly valuable for developing therapies that target complex diseases, such as cancer and autoimmune disorders, where precise and efficient purification processes are essential.
Industry Recognition for Innovation and Excellence
The Asia-Pacific Biopharma Excellence Awards (ABEA) recognize exceptional contributions to the biopharma industry across various sectors, including bioprocessing, biologics, clinical trials, and aseptic fill and finish. The awards celebrate organizations and technologies that have made significant advancements in these areas, helping to improve the quality, speed, and scalability of biopharma manufacturing across the Asia-Pacific region.
Winners of the ABEA awards are selected by a panel of industry experts based on their achievements and innovations in advancing bioprocessing. The recognition of Avantor as a leader in single-use systems and chromatography highlights the company’s continued investment in cutting-edge solutions and its dedication to helping biopharmaceutical companies address the challenges of manufacturing high-quality therapies.
Avantor®’s Commitment to Advancing Biomanufacturing
Narayana Rao Rapolu, VP & GM of BPS AMEA at Avantor, expressed his appreciation for the recognition: “We are honored to receive these two awards, which acknowledge the hard work and dedication of our team in advancing biomanufacturing. As biologics become more complex, Avantor remains committed to delivering innovative chromatography and single-use solutions that enhance flexibility, efficiency, and cost-effectiveness globally. By leveraging our wide range of chromatography resins, process chemicals, and reagents, our application scientists and customer support centers are able to provide total solutions that improve process efficiency.”
Rajesh Bhagwat, Director of Strategy and Marketing for BPS AMEA at Avantor, added: “Avantor’s expertise in delivering customized, scalable solutions is a driving force behind innovation in biopharmaceutical manufacturing. Our advanced chromatography resins, including PROchievA and J.T. Baker® Bakerbond®, offer unique selectivity for next-generation therapies across the Asia-Pacific region. This award reaffirms our commitment to supporting our customers at every stage, from small-scale development to large-scale production.”
Looking Ahead: Supporting the Future of Biopharma Manufacturing
Avantor’s recognition at the ABEA 2025 underscores its role as a leader in the biopharma manufacturing space. The company continues to prioritize innovation and customer-centric solutions, ensuring that biopharmaceutical companies have the tools and resources they need to manufacture high-quality therapies that meet the evolving demands of the global healthcare landscape.
By providing flexible, scalable, and efficient solutions, Avantor is helping biopharma companies navigate the complex challenges of drug development and manufacturing. As the industry moves forward, Avantor will remain at the forefront, continuing to deliver breakthrough technologies and services that improve patient outcomes and support the future of biopharmaceutical manufacturing worldwide.
About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit avantorsciences.com and find us on LinkedIn, X (Twitter) and Facebook.
